Cyclin L2 Antikörper (Middle Region)
Kurzübersicht für Cyclin L2 Antikörper (Middle Region) (ABIN951764)
Target
Alle Cyclin L2 (CCNL2) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 345-374, Middle Region
-
Spezifität
- This antibody reacts to CCNL2.
-
Kreuzreaktivität (Details)
- Species reactivity (tested):Human.
-
Aufreinigung
- Affinity chromatography on Protein A
-
Immunogen
- KLH conjugated synthetic peptide between 345-374 amino acids from the Central region of human CCNL2
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS, 0.09 % (W/V) sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- Cyclin L2 (CCNL2)
-
Andere Bezeichnung
- Cyclin L2
-
Hintergrund
- CCNL2 is a transcriptional regulator which participates in regulating the pre-mRNA splicing process. Also modulates the expression of critical apoptotic factor, leading to cell apoptosis.Synonyms: CCNL2, Cyclin-L2, SB138
-
Molekulargewicht
- 58147 Da
-
Gen-ID
- 81669
-
NCBI Accession
- NP_001034666
Target
-